Cargando…

Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model

Severe lower respiratory tract infection in infants and small children is commonly caused by respiratory syncytial virus (RSV). Palivizumab (Synagis(®)), a humanized IgG(1) monoclonal antibody (mAb) approved for RSV immunoprophylaxis in at-risk neonates, is highly effective, but pharmacoeconomic ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeitlin, Larry, Bohorov, Ognian, Bohorova, Natasha, Hiatt, Andrew, Kim, Do H., Pauly, Michael H., Velasco, Jesus, Whaley, Kevin J., Barnard, Dale L., Bates, John T., Crowe, James E., Piedra, Pedro A., Gilbert, Brian E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893236/ https://www.ncbi.nlm.nih.gov/pubmed/23396091 http://dx.doi.org/10.4161/mabs.23281

Ejemplares similares

Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
por: Castilho, Alexandra, et al.
Publicado: (2011)

Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana
por: Swope, Kelsi, et al.
Publicado: (2022)

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™)
por: Qiu, Xiangguo, et al.
Publicado: (2014)

Multiantibody Strategies for HIV
por: Hiatt, Andrew, et al.
Publicado: (2013)

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
por: Johnson, Reed F., et al.
Publicado: (2016)

Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
por: Richards, Angelene F., et al.
Publicado: (2020)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
por: Zeitlin, L, et al.
Publicado: (1999)

Correlative outcomes of maternal immunization against RSV in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2022)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication
por: Rong, Yinghui, et al.
Publicado: (2020)

Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
por: Whaley, Kevin J, et al.
Publicado: (2021)

Engineering monoclonal antibody-based contraception and multipurpose prevention technologies(†)
por: Anderson, Deborah J, et al.
Publicado: (2020)

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
por: Stobart, Christopher C., et al.
Publicado: (2016)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

2592. Lung Function as an Indicator of Vaccine Enhanced RSV Disease in Cotton Rats
por: Jones, Crystal, et al.
Publicado: (2019)

Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women
por: Baldeon-Vaca, Gabriela, et al.
Publicado: (2021)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3
por: Tsekoa, Tsepo Lebiletsa, et al.
Publicado: (2016)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
por: Zeitlin, Larry, et al.
Publicado: (2021)

Transcriptome reprogramming in the shoot apical meristem of CymRSV‐infected Nicotiana benthamiana plants associates with viral exclusion and the lack of recovery
por: Medzihradszky, Anna, et al.
Publicado: (2019)

Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients
por: Ye, Xunyan, et al.
Publicado: (2021)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies
por: Verreault, Daniel, et al.
Publicado: (2019)

Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease
por: McGill, Jodi L., et al.
Publicado: (2019)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Non-gradient and genotype-dependent patterns of RSV gene expression
por: Piedra, Felipe-Andrés, et al.
Publicado: (2020)

Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
por: Chen, Zhifeng, et al.
Publicado: (2016)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
por: Ananworanich, Jintanat, et al.
Publicado: (2021)

Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children
por: Zheng, Zhe, et al.
Publicado: (2022)

Subtractive Immunization as a Method to Develop Respiratory Syncytial Virus (RSV)—Specific Monoclonal Antibodies
por: Jacobs, Lotte, et al.
Publicado: (2023)

Monoclonal antibodies for prophylactic and therapeutic use against viral infections
por: Both, Leonard, et al.
Publicado: (2013)

Monoclonal antibodies for prophylactic and therapeutic use against viral infections()
por: Both, Leonard, et al.
Publicado: (2013)

383. Pharmacokinetics and Safety in Healthy Adults of RSM01, a Novel RSV Monoclonal Antibody, and Population PK Modeling to Support Pediatric Development
por: Levi, Micha, et al.
Publicado: (2023)

Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
por: Jadhao, Samadhan J., et al.
Publicado: (2016)

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
por: Raghunandan, Rama, et al.
Publicado: (2014)

2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2019)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e905jgsqtep0srrltu4dvalqif